Palenschat Medical & Surgical Svcs is categorized under Services (Unclassified) in Bonita, CA and active since 2009.
Palenschat Medical & Surgical Svcs was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Services (Unclassified) business, which does work in the B2B market, and is classified as a Services (Unclassified), under code number 541990 by the NAICS.
If you are seeking more information, feel free to contact Palenschat Douglas at the company’s single location by writing to 5741 Central Avenue, Bonita, California CA 91902 or by phoning (619) 434-9695. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Palenschat Medical & Surgical Svcs |
Contact Person: | Palenschat Douglas |
Address: | 5741 Central Avenue, Bonita, California 91902 |
Phone Number: | (619) 434-9695 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2009 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Services (Unclassified) |
SIC Code: | 8999 |
NAICS Code: | 541990 |
Share This Business: |
Palenschat Medical & Surgical Svcs was started in 2009 to provide professional Services (Unclassified) under the SIC code 8999 and NAICS code 541990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Palenschat Douglas for inquiries that concern Palenschat Medical & Surgical Svcs by calling the company number (619) 434-9695, as your correspondence is most welcome. Additionally, the physical location of the single location of Palenschat Medical & Surgical Svcs can be found at the coordinates 32.671885,-117.007432 as well as the street address 5741 Central Avenue in Bonita, California 91902.
For its online presence, you may visit Palenschat Medical & Surgical Svcs’s website at and engage with its social media outlets through on Twitter and on Facebook.